We are an internally managed REIT that acquires, owns, and manages primarily single-tenant commercial real estate properties that are net leased on a long-term basis to a diversified group of tenants. We utilize an investment strategy underpinned by strong fundamental credit analysis and prudent real estate underwriting. Since our inception in 2007, we have […]

We will seek to capitalize on the decades of experience and relationships of our management team, including Anthony Kenney, our CEO and director nominee. Mr. Kenney previously worked for Marathon Petroleum Corporation (NYSE: MPC) (“MPC”) for the past 43 years and recently retired as President of its Speedway division, which he led since 2005. Under […]

  GameWorks is an esports and entertainment destination built around the central theme of gaming, both competitively and for amusement. Every location, which has a footprint ranging (on average) from approximately 20,000 to 35,000 square feet, features a wide variety of the latest and most popular arcade and video games as well as esports and […]

(Note: This is not a traditional IPO. This is a direct listing. The company has applied to have its stock listed on the NASDAQ. No pricing terms have been disclosed. *I-Bankers is the financial advisor on this direct listing. There are no underwriters.) Thryv Holdings, Inc. is dedicated to supporting local, independent businesses and franchises […]

We are a clinical-stage precision oncology company focused on discovering and developing small molecule therapies optimized to target the key driver mechanisms in cancers affecting patients with high unmet need, where there are limited or no treatment options. Since our inception in 2016, we have received clearance from the U.S. Food and Drug Administration, or the […]

We are a precision oncology company pioneering the discovery and development of small molecule, tumor-agnostic therapies targeting p53 mutations. p53 is a well-defined tumor suppressor protein known as the “guardian of the genome,” and normal, or wild-type, p53 has the ability to eliminate cancer cells. However, mutant p53 proteins can be misfolded and lose their […]

Since 2017, we have focused on the residential property rental industry in China. We leased residential properties from individual property owners on a long-term basis, renovated and furnished such properties in a clean and modern manner, and rented them out to individual tenants. As of June 30, 2019, we leased 11,434 properties from property owners. On July […]

We are a newly organized blank check company. We intend to pursue opportunities created by the accelerating transition toward sustainable use of energy and natural resources. The renewable energy sector has emerged from a niche source of electricity to be the key driver of growth in the industry, with an estimated $1.5 trillion invested globally […]

We are a newly organized blank check company. Our sponsor is affiliated with Victory Park Capital Advisors, LLC (VPC), a registered investment advisor. We intend to identify high-growth Fintech acquisition targets with an enterprise value of approximately $800 million to $2.0 billion by leveraging the expertise of our management team and VPC.   

We are a clinical-stage biopharmaceutical company focused on developing transformative medicines for the treatment of diseases of the retina and optic nerve. Our novel proprietary technologies are designed to release drugs in ocular tissue at a controlled rate for up to 12 months in order to improve patient compliance, reduce healthcare burdens and, ultimately, deliver […]